8.86%C 6.45 22.20%F 2.55 5.20%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
WALTHAM, Mass. - Lab supply and scientific instrument maker Thermo Fisher Scientific Inc. on Thursday said it bought privately held Affinity BioReagents for an undisclosed amount.
Golden, Colo.-based Affinity has made more than 35,000 reagents, which are used in medical and academic research and drug discovery. The company also makes antibodies, which are proteins the immune system makes in response to foreign substances, and recombinant proteins. Thermo Fisher will make Affinity part of its Analytical Technologies business.
Affinity BioReagents had approximately $6 million in revenue in 2007.
On July 1, Thermo Fisher bought Open Biosystems Inc., which develops tools to help scientists learn how to shut off genes that trigger disease. Open Biosystems was also bought for an undisclosed amount, and was added to the Analytic Technologies unit.
In afternoon trading, Thermo Fisher stock rose 70 cents to $57.18.
Major U.S. stock indexes slumped further south midday Monday, further extending this morning's hefty losses which erased last week's f...
China markets opened lower on Tuesday morning as the investors' confidence hit by the signals that global recession are deepening.
The dollar edged higher against the Swiss franc late Monday night. The U.S. currency was worth 1.2037 Swiss francs, up slightly from the 1.2028 f...
|
Building your business and corporate credit for your small business.
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
